Quality Executive Partners - IACET Accreditation

A Milestone Achievement in Pharmaceutical Education

We are thrilled to announce a significant milestone that sets Virtuosi apart in the world of pharmaceutical education. Quality Executive Partners, Inc.® (QxP), the expert development team behind Virtuosi®, has now been accredited by the International Accreditors for Continuing Education and Training (IACET). This prestigious accreditation is not just a recognition of our excellence; it's a testament to the value and impact that our Virtuosi learning events bring to pharmaceutical manufacturing companies and their employees through meeting and exceeding the standard for adult education and continuous improvement.

The IACET Standard - The Benchmark of Learning Excellence

IACET is recognized globally as the premier standard-setting organization in continuing education and training, guided by the ANSI/IACET1-2018 Standard for Continuing Education and Training. IACET’s standards ensure the highest quality in educational processes and outcomes. QxP’s accreditation signifies our commitment to developing effective and valuable continuing education programs. It underscores our dedication to excellence, from our procedures and processes to the tangible results that will be realized in your company.

Why This Matters for Your Company

For leaders and employees in the pharmaceutical manufacturing industry, the accreditation of QxP means more than just an external validation of our educational content. It signifies:

  • A Magnet for Talent: By educating your teams with Virtuosi, your company becomes an attractive prospect for professionals who prioritize growth and development. As an IACET Accredited Provider, Quality Executive Partners offers IACET CEUs (Continuing Education Units) for its Virtuosi learning events that comply with the ANSI/IACET Continuing Education and Training Standard. These CEUs carry weight across the industry, enhancing your ability to recruit and retain the best minds.
  • Enhanced Product Quality: The comprehensive assessment QxP has undergone assures that our Virtuosi educational system not only meets but exceeds global standards in adult education and continuous improvement. This directly translates into higher quality training for your staff, fostering improved operational efficiency, innovation, and ultimately, a higher quality product.
  • Regulatory Confidence: The IACET accreditation is utilized by several government entities and agencies as a benchmark for quality. This means regulatory agencies can lean on QxP’s accreditation as part of their training provider or course approval programs, saving resources while ensuring compliance.
  • Continuous Improvement: The accreditation process involved a deep dive into the latest best practices in adult learning, conducted by a commission of professionals around the globe. This ensures that the Virtuosi education provided by QxP is not just current but cutting edge, committed to continuous learning and improvement.

A Commitment to Your Success

QxP has created the only educational system in the Pharma industry accredited by IACET.

This unique position allows us to offer unparalleled value to your organization, ensuring your teams are not just trained but transformed. We understand the challenges you face in maintaining competitive edges, fostering innovation, and ensuring regulatory compliance. QxP’s IACET accreditation for our Virtuosi learning events is our promise to you that your investment in your team’s education is a step towards meeting those challenges head-on, with confidence.

Join Us in Celebrating This Achievement

As we celebrate this milestone, we invite you to explore how our Virtuosi platform can elevate your organization's learning culture. Discover the difference that globally recognized, high-quality education can make in providing confidence to your teams, enhancing product quality, and driving success in the highly competitive pharmaceutical industry.

Your partnership with QxP and our Virtuosi learning platform is more than just an educational investment; it’s a commitment to excellence, innovation, and the future of pharmaceutical manufacturing. Let’s embark on this journey of continuous improvement and excellence together.

Pharmaceutical Predictions for 2025

Christine Feaster
December 11, 2024

The Crucial Nexus: Data Integrity in Pharmaceutical Manufacturing

Christine Feaster
May 17, 2024

Pharmaceutical Industry Trends for 2024 So Far

Christine Feaster
April 24, 2024

Decoding the Technical Transfer Process in Biotech Manufacturing

Sarah Boynton
April 23, 2024

Coaching and Correcting: A Focus on Behavior Over Blame

Sarah Boynton
November 1, 2023

The Importance of Roles and Responsibilities in Biotech Manufacturing & Human Error Prevention

Sarah Boynton
October 26, 2023

Remote cGMP Inspections and AI in Drug Manufacturing

Michelle Fishburne
October 11, 2023

4 Best Practices for Effective Investigation into Deviations

Sarah Boynton
September 19, 2023

The Art of Viral Vector Manufacturing: 4 Essential Controls to Prevent Cross-Contamination

Sarah Boynton
September 13, 2023

Practicing Risk Acceptance

Mark Roache
August 28, 2023

Annex 1 – Can we all take a deep breath now?

Vanessa Figueroa
August 24, 2023

In Cell and Gene, Good Science is Necessary, But Not Sufficient

Mark Roache
August 21, 2023

6 Ways To Achieve Manufacturing Audit And Inspection Readiness

Sarah Boynton
August 14, 2023

Experience is What You Get Just After You Needed It, Part 2

Mark Roache
August 10, 2023

Experience is What You Get Just After You Needed It, Part 1

Mark Roache
August 10, 2023

Sterility Assurance Matters to This ONE

Greg Gibb
August 8, 2023

Enhancing Quality and Safety: 3 Essential Human Error Prevention Tools for cGMP Manufacturing

Sarah Boynton
August 3, 2023

Asia-Pacific Happenings: Samsung Bioepis Implements QxP Virtuosi®

Michelle Fishburne
August 2, 2023

CDMOs – Selecting the Right One for Each Manufacturing Stage

Christine Feaster
July 24, 2023

3 Types of Human Error and Potential CAPAs to Prevent Them

Sarah Boynton
July 20, 2023

Drug Shortages: Causes & Solutions

Christine Feaster
July 10, 2023

The 5 Questions You Need to Ask After a Human Error Event Occurs

Sarah Boynton
July 5, 2023

Understanding How Adults Learn

Mike Levitt
June 30, 2023

Annex 1 and Ensuring Filling Technologies Fit the Need

Natasha Howard
June 21, 2023

How to Solve Pharma’s Skilled Workforce Deficit

Jeff Roy
June 20, 2023

ChatGPT Told Me AI is “Imperative” in Pharma Manufacturing

No items found.
June 18, 2023

Get Ready: FDORA’s Unannounced Foreign Inspection Pilot Program is On!

Crystal Mersh
June 6, 2023

Nitrosamines Impurity Challenges

Christine Feaster
June 2, 2023

All You Need to Know About Contamination Control Strategies, Parts 1 and 2

No items found.
June 1, 2023

When is ISO 8 Not ISO 8?

Bob Ferer
May 30, 2023

Cost Of Quality: Worth Every Cent In Bio/Pharmaceutical Manufacturing

Crystal Mersh
May 24, 2023

Pharmaceutical Quality is NOT a Spectator Sport

Mike Levitt
May 22, 2023

The Six Keys for Effective Deviation Investigators

Mike Levitt
May 18, 2023

There Has to be a Better Way to Train

Tyler DeWitt, Ph.D.
May 15, 2023

Cell and Gene: Article Series on CGT’s Key Drivers

Mark Roache
May 8, 2023

Bacterial Endotoxin Testing is on the Move

Christine Feaster
May 5, 2023

Top 20 Pharma Company Chooses QxP Virtuosi® Platform

Vanessa Figueroa
May 3, 2023

Crystal Clear: Controls Are Not Enough

Crystal Mersh
April 22, 2023

Myth #1: Complying with Regulations and Product Specifications

Brian Duncan
April 20, 2023

Myth #2: Proactively Remediating Bad Inspection Outcomes: What’s the benefit?

Brian Duncan
April 20, 2023

Is it Time to Outsource Internal Auditing?

Mike Levitt
April 18, 2023

Quality is Number One, Even When Trying to Address Supply Chain Issues

Christine Feaster
April 14, 2023

Don’t Be a Daredevil When Retrofitting Your Facility, Part 2

Bob Ferer
April 10, 2023

Don’t Be a Daredevil When Retrofitting Your Facility, Part 1

Bob Ferer
April 10, 2023